If we have little faith in chelation therapy, then it is hard to turn 180 degrees with a positive result and suddenly completely believe in it and recommend its use.
"This is a completely new way of treating HER2-positive breast cancer, " said Kimberly Blackwell, the study's lead researcher and a professor of medicine at Duke University.
Kadcyla, known as an "antibody-drug conjugate, " represents "a completely new way" to treat HER2 positive metastatic breast cancer, said Dr. Hal Barron, chief medical officer and head of global product development for Genentech.